ColonRectalFamily PracticeGastroenterologyHematology & OncologyInternal MedicinePathologyColon CancerRectal CancerCancerColonoscopy
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, March 29, 2019 (HealthDay News) -- Starting colorectal cancer (CRC) screening at age 45 instead of 50 years seems cost-effective, but greater benefits could be achieved by increasing participation rates for unscreened older individuals, according to a study published online March 28 in Gastroenterology.
Uri Ladabaum, M.D., from the Stanford University School of Medicine in California, and colleagues estimated the cost-effectiveness and national effects of adopting the American Cancer Society recommendation for initiating CRC screening at age 45 instead of 50 years.
The researchers found that initiation of screening colonoscopy at age 45 instead of 50 years would avert four CRCs and two CRC deaths per 1,000 individuals and would yield 14 quality-adjusted life years (QALY) gained, cost $33,900 per QALY gained, and require an additional 758 colonoscopies. Using these 758 colonoscopies to instead screen 231 currently unscreened 55-year-olds or 342 currently unscreened 65-year-olds through age 75 years would result in 13 to 14 CRC cases being averted, six to seven CRC deaths being averted, and 27 to 28 discounted QALYs gained, while saving $163,700 to $445,800. Greater benefits and savings were generated by improving colonoscopy completion rates after abnormal results from a fecal immunochemical test.
"Research to determine the yield of average-risk CRC screening beginning at age 45 and its impact on screening participation at older ages will be invaluable to inform future practice guidelines," the authors write.
One author disclosed financial ties to the pharmaceutical and medical device industries.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 27, 2022
Read this Next
Other Trending Articles